Recents Post

Gigasoft 2026 JavaScript Chart Comparison: ProEssentials, Highcharts, SciChart, LightningChart, ECharts

Gigasoft 2026 JavaScript Chart Comparison: ProEssentials, Highcharts, SciChart, LightningChart, ECharts

Back-to-School Health: Helping Children Start the School Year Strong with Accordia Health

Back-to-School Health: Helping Children Start the School Year Strong with Accordia Health

SBVA Appoints Two Global Investment Veterans as Venture Partners to Strengthen Portfolio Growth Support

SBVA Appoints Two Global Investment Veterans as Venture Partners to Strengthen Portfolio Growth Support

BABA ALERT: Alibaba Group Holding Limited (NYSE: BABA) Investors Urged to Contact Hagens Berman

BABA ALERT: Alibaba Group Holding Limited (NYSE: BABA) Investors Urged to Contact Hagens Berman

Ovintiv Announces Permian and Montney Inventory Additions

Ovintiv Announces Permian and Montney Inventory Additions

Tree Service in Spring Hill FL: Complete Care for Residential Properties

Tree Service in Spring Hill FL: Complete Care for Residential Properties

Symbos Receives Frost & Sullivan’s 2026 Australian Transformational Innovation Leadership Recognition for its Customer Experience Management Services

Symbos Receives Frost & Sullivan’s 2026 Australian Transformational Innovation Leadership Recognition for its Customer Experience Management Services

Caladan Goes Live on BitGo’s Go Network for Institutional Settlement

Caladan Goes Live on BitGo’s Go Network for Institutional Settlement

Back-to-school spending has become a stress test for household finances

Back-to-school spending has become a stress test for household finances

Egg Tuck to Bring Its Signature Soft-Scrambled Egg Sandwiches to San Diego’s Little Italy

Egg Tuck to Bring Its Signature Soft-Scrambled Egg Sandwiches to San Diego’s Little Italy

Technology

Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-Class Single-Domain Antibody-Based BBB-Crossing Technology for CNS Diseases

CAMBRIDGE, Mass., July 1, 2026 /PRNewswire/ — Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, today announced a strategic collaboration with Lonza to develop best-in-class single-domain antibody–based blood-brain barrier (BBB)-crossing…

Read the full release →

News provided by PR Newswire.